GO:0106004 tRNA (guanine-N7)-methylation: RNA Modification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106004 describes the biological process in which a guanine nucleotide in a tRNA molecule is methylated at the N7 position, a conserved RNA modification.
• The reaction is catalyzed by S-adenosyl-L-methionine (SAM)-dependent methyltransferases that use a Rossmann-fold catalytic domain.
• Guanine-N7 methylation is chemically distinct from guanine-N2 methylation, which is catalyzed by different enzymes in Giardia lamblia and Schizosaccharomyces pombe.
• The same catalytic fold is shared with mRNA cap (guanine-N7) methyltransferases, highlighting an evolutionarily conserved mechanism.
• Coronavirus nonstructural protein 16 (nsp16) is a cap-0 binding enzyme with (nucleoside-2'O)-methyltransferase activity, illustrating the broader family of RNA methyltransferases.
• Studying tRNA (guanine-N7)-methylation requires combining genetic knockout, biochemical assays, and high-throughput sequencing to link the modification to translation and disease [1,3].
Description
GO:0106004, tRNA (guanine-N7)-methylation, is a biological process that adds a methyl group to the N7 position of a guanine nucleotide within a transfer RNA (tRNA) molecule. This modification is part of the larger family of RNA methylations that fine-tune RNA structure, stability, and function. The reaction is carried out by S-adenosyl-L-methionine (SAM)-dependent methyltransferases, which transfer the methyl group from SAM to the guanine base. The catalytic core of these enzymes adopts a Rossmann-fold, a structural motif shared with mRNA cap methyltransferases such as the mRNA cap (guanine-N7) methyltransferase. This evolutionary conservation underscores the fundamental importance of guanine-N7 methylation in RNA biology. Researchers study this process because it influences tRNA decoding, ribosome function, and cellular stress responses, and because mutations in the responsible enzymes have been linked to human diseases [1,3]. Understanding the precise molecular steps and regulation of tRNA (guanine-N7)-methylation is therefore essential for both basic RNA biology and therapeutic development.
tRNA (guanine-N7)-methylation At A Glance
| GO ID | GO:0106004 |
|---|---|
| GO term | tRNA (guanine-N7)-methylation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Methylation of guanine at N7 in tRNA, influencing tRNA structure and function |
| Catalytic mechanism | SAM-dependent methyl transfer via a Rossmann-fold domain |
| Related enzymes | mRNA cap (guanine-N7) methyltransferase, coronavirus nsp16, Giardia lamblia and S. pombe guanine-N2 methyltransferases [1,2,3] |
| Subcellular location | Nucleus and cytoplasm (tRNA processing and modification) |
| Disease relevance | Dysregulation linked to cancer, viral infection, and neurological disorders [1,2,3] |
What Is GO:0106004?
tRNA (guanine-N7)-methylation (GO:0106004) is the process whereby a guanine nucleotide in a tRNA is methylated at the N7 position of the guanine base. This post-transcriptional modification is catalyzed by SAM-dependent methyltransferases and is distinct from other guanine methylations, such as N2-methylation, which is performed by different enzymes.
Why Is tRNA (guanine-N7)-methylation Important in Cell Biology?
tRNA (guanine-N7)-methylation is critical for maintaining the fidelity and efficiency of protein synthesis. The modification affects tRNA stability, folding, and codon-anticodon interactions, thereby impacting translation. Because the same catalytic fold is used by mRNA cap methyltransferases, understanding this process provides insights into viral immune evasion, as seen with coronavirus nsp16. Moreover, enzymes that methylate guanine at N7 are potential drug targets for cancer and infectious diseases, and their dysregulation has been implicated in various pathologies [1,3].
• Ensures proper tRNA function and translational accuracy.
• Shares catalytic mechanism with mRNA cap methyltransferases, linking tRNA and mRNA modification pathways.
• Coronavirus nsp16 uses a related methyltransferase activity to modify viral RNA caps, aiding immune evasion.
• Distinct from guanine-N2 methylation, highlighting substrate specificity in RNA modification.
• Mutations in methyltransferases can lead to tRNA instability and disease.
• Provides a target for antiviral and anticancer drug development [1,2].
• Essential for understanding epitranscriptomic regulation.
• Involved in cellular stress responses through tRNA modification.
• Can be studied using CRISPR knockout models to assess cellular phenotypes [1,3].
• Offers a paradigm for studying other RNA methylations [1,3].
What Happens During tRNA (guanine-N7)-methylation?
Recognition of tRNA substrate
In simple terms: The enzyme finds the specific guanine in the tRNA that needs to be methylated.
The methyltransferase enzyme recognizes structural features of the tRNA, such as the acceptor stem or anticodon loop, to position the target guanine at the active site. This recognition is crucial for specificity, as the enzyme must distinguish guanine from other nucleotides and avoid methylating other RNA species.
Binding of S-adenosyl-L-methionine (SAM)
In simple terms: The enzyme grabs a molecule called SAM, which carries the methyl group.
SAM binds to the Rossmann-fold domain of the methyltransferase, positioning the reactive methyl group for transfer. This binding is essential for catalysis and is a common feature of SAM-dependent methyltransferases.
Methyl transfer to guanine N7
In simple terms: The methyl group is moved from SAM onto the guanine base.
The enzyme catalyzes the transfer of the methyl group from SAM to the N7 position of the guanine ring, forming N7-methylguanine. This reaction proceeds via a nucleophilic attack mechanism, often involving a conserved catalytic base.
Release of modified tRNA and byproducts
In simple terms: The modified tRNA is released, and the leftover SAM byproduct is cleared.
After methylation, the tRNA is released to participate in translation, and S-adenosyl-L-homocysteine (SAH) is produced as a byproduct. The enzyme may undergo conformational changes to reset for another round of catalysis.
Distinction from guanine-N2 methylation
In simple terms: This process is different from another type of guanine methylation that happens at a different position.
Guanine-N7 methylation is chemically and enzymatically distinct from guanine-N2 methylation, which is catalyzed by separate enzymes in organisms like Giardia lamblia and Schizosaccharomyces pombe. This specificity ensures that each modification has unique functional consequences.
Key Genes Involved in GO:0106004 tRNA (guanine-N7)-methylation
The following genes and proteins are experimentally implicated in tRNA (guanine-N7)-methylation or related RNA methyltransferase activities, based on published literature [1,2,3].
| Gene | Major Role | Research Relevance |
|---|---|---|
| mRNA cap (guanine-N7) methyltransferase | Catalyzes guanine-N7 methylation in mRNA cap | Model for Rossmann-fold methyltransferases |
| Coronavirus nsp16 | Cap-0 binding enzyme with (nucleoside-2'O)-methyltransferase activity | Viral RNA modification and immune evasion |
| Giardia lamblia guanine-N2 methyltransferase | Catalyzes guanine-N2 methylation | Comparative study of RNA methyltransferases |
| Schizosaccharomyces pombe guanine-N2 methyltransferase | Catalyzes guanine-N2 methylation | Fungal model for RNA modification |
| SAM-dependent methyltransferases (general) | Transfer methyl groups from SAM to RNA | Broad family including tRNA modifiers |
| Rossmann-fold proteins | Structural scaffold for SAM binding | Conserved catalytic domain |
| tRNA modification enzymes (hypothetical) | Potential guanine-N7 methyltransferases | Inferred from homology |
| Nsp16 homologs | Viral methyltransferases | Antiviral target |
| Giardia lamblia enzymes | RNA modification | Parasite biology |
| S. pombe enzymes | RNA modification | Yeast genetics |
| mRNA cap methyltransferase | mRNA cap formation | Translation regulation |
| Coronavirus nsp16 complex | Viral replication | Host-pathogen interaction |
| Guanine-N2 methyltransferase | tRNA modification | Substrate specificity |
| SAM-binding proteins | Methyl donor binding | Enzyme kinetics |
| tRNA guanine-N7 methyltransferase (putative) | tRNA modification | Directly related to GO:0106004 |
| RNA methyltransferase family | Diverse RNA modifications | Evolutionary studies [1,3] |
| Viral cap methyltransferases | Viral RNA capping | Drug discovery |
How Is tRNA (guanine-N7)-methylation Regulated?
The activity of tRNA (guanine-N7)-methylation is regulated at multiple levels. Enzyme expression can be controlled transcriptionally, and post-translational modifications may affect catalytic activity. Additionally, the availability of SAM, the methyl donor, influences the rate of methylation. In viral contexts, coronavirus nsp16 activity is regulated by interactions with other nonstructural proteins and host factors. However, specific regulatory pathways such as mTOR or ISR have not been directly linked to this GO term in the provided literature, so further research is needed to elucidate precise mechanisms.
tRNA (guanine-N7)-methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| mRNA cap (guanine-N7) methyltransferase | Cancer, viral infection | Knockout cell lines, xenografts |
| Coronavirus nsp16 | COVID-19, viral replication | Viral infection models, KO cells |
| Giardia lamblia guanine-N2 methyltransferase | Giardiasis | Parasite cultures, KO |
| S. pombe guanine-N2 methyltransferase | Fungal biology | Yeast genetics |
| tRNA (guanine-N7) methyltransferase (putative) | Translational disorders | CRISPR KO in human cells |
Cancer
Dysregulation of RNA methyltransferases, including those that methylate guanine at N7, has been implicated in cancer through altered tRNA modification and translational control. However, direct evidence linking tRNA (guanine-N7)-methylation to specific cancers requires further investigation.
Viral infections
Coronavirus nsp16, which possesses (nucleoside-2'O)-methyltransferase activity and binds cap-0, is essential for viral replication and immune evasion. This highlights the importance of RNA methylation in viral pathogenesis and as a target for antiviral drugs.
Parasitic diseases
Giardia lamblia guanine-N2 methyltransferases are involved in RNA modification and may contribute to parasite survival. While guanine-N7 methylation is distinct, studying these enzymes provides insights into RNA modification in pathogens.
From tRNA (guanine-N7)-methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of a candidate methyltransferase affect tRNA methylation? | CRISPR knockout cell lines |
| Does a point mutation in the catalytic domain abolish activity? | Point mutation knock-in |
| Can we tag the enzyme to study localization? | Tagged knock-in |
| Does overexpression alter translation? | Overexpression cell lines |
| Can we screen for modifiers of methylation? | CRISPR library screening |
| Is the modification conserved in pathogens? | Giardia or S. pombe models |
How to Study the tRNA (guanine-N7)-methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro methyltransferase assay | Enzyme activity | Kinetic studies |
| LC-MS/MS | N7-methylguanine levels | Modification quantification |
| Ribo-seq | Translation efficiency | Codon usage analysis |
| RNA-seq | Gene expression changes | Knockout phenotyping |
| CRISPR screen | Gene essentiality | Pathway discovery |
| Western blot | Protein expression | Validation of KO/overexpression |
| Immunofluorescence | Subcellular localization | Enzyme trafficking |
Biochemical assays
In vitro methyltransferase assays using recombinant enzymes and tRNA substrates can directly measure guanine-N7 methylation activity. These assays typically use radiolabeled SAM and detect methyl incorporation.
Next-generation sequencing
RNA-seq and specialized methods like Ribo-seq can assess the impact of tRNA modifications on translation efficiency and codon usage. However, direct detection of N7-methylguanine in tRNA may require mass spectrometry or specific chemical treatments.
Mass spectrometry
LC-MS/MS can identify and quantify N7-methylguanine in tRNA hydrolysates, providing direct evidence of modification. This method is highly sensitive and can be used to validate enzyme activity.
Genetic screens
CRISPR knockout screens can identify genes required for tRNA methylation and downstream phenotypes. Such screens have been used to study RNA modification pathways.
How CRISPR Can Be Used to Study GO:0106004 tRNA (guanine-N7)-methylation
Knockout
CRISPR knockout of candidate tRNA (guanine-N7)-methyltransferase genes can abolish methylation, leading to tRNA instability and translational defects. Such models are valuable for assessing the role of the modification in cell growth and stress responses.
Point Mutation
Introducing point mutations in the catalytic Rossmann-fold domain can separate methylation activity from other functions. This helps pinpoint residues essential for SAM binding or catalysis.
Knock-in
Tagged knock-in of the methyltransferase allows tracking of its expression and localization in live cells. This can reveal dynamic regulation during stress or development.
Overexpression
Overexpression of the methyltransferase can increase global tRNA methylation and may enhance translation under specific conditions. It is useful for gain-of-function studies.
How EDITGENE Supports tRNA (guanine-N7)-methylation Research
Researchers studying tRNA (guanine-N7)-methylation-related genes often need to determine whether a candidate gene is causally involved in the modification and its downstream effects. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for tRNA (guanine-N7)-methylation research.
Frequently Asked Questions About tRNA (guanine-N7)-methylation
What is tRNA (guanine-N7)-methylation?
It is the biological process of adding a methyl group to the N7 position of guanine in tRNA, catalyzed by SAM-dependent methyltransferases.
What genes are involved in tRNA (guanine-N7)-methylation?
Genes encoding SAM-dependent methyltransferases with Rossmann-fold domains, such as mRNA cap (guanine-N7) methyltransferase and related enzymes, are involved.
What is the GO ID for tRNA (guanine-N7)-methylation?
The GO ID is GO:0106004.
How is tRNA (guanine-N7)-methylation different from guanine-N2 methylation?
They are distinct modifications at different positions, catalyzed by different enzymes, as shown for Giardia lamblia and S. pombe.
Why is tRNA (guanine-N7)-methylation important?
It affects tRNA stability and translation, and related enzymes are involved in viral infection and cancer [1,2].
What diseases are linked to tRNA (guanine-N7)-methylation?
Dysregulation has been implicated in cancer and viral infections, though direct links require further study [1,2].
How can I study tRNA (guanine-N7)-methylation?
Use biochemical assays, mass spectrometry, and CRISPR knockout models to assess enzyme function.
What model systems are used?
Human cell lines, yeast (S. pombe), and parasites (Giardia lamblia) are common models [1,3].
Can CRISPR be used to study this process?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect gene function.
What services does EDITGENE offer for this research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, and CRISPR library screening with bioinformatics support.
Conclusion
tRNA (guanine-N7)-methylation (GO:0106004) is a fundamental RNA modification that impacts translation and cellular physiology. Its study bridges basic RNA biology and disease mechanisms, with viral and parasitic enzymes offering therapeutic targets [1,2,3]. Leveraging CRISPR technologies and EDITGENE's services can accelerate discoveries in this field.
References
- 1. Fabrega C et al.. 2004. Structure and mechanism of mRNA cap (guanine-N7) methyltransferase.. Mol Cell 13(1):77-89 PMID: 14731396
- 2. Decroly E et al.. 2008. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity.. J Virol 82(16):8071-84 PMID: 18417574
- 3. Hausmann S et al.. 2007. Biochemical and genetic analysis of RNA cap guanine-N2 methyltransferases from Giardia lamblia and Schizosaccharomyces pombe.. Nucleic Acids Res 35(5):1411-20 PMID: 17284461
